Shelby

Shelby is committed to facilitating step-change technologies in bio and health and also sees incredible potential in broadening the the use-cases and efficiency in these sectors. Before investing at Compound, they’ve worked as a bioscience researcher across plant sciences (PhD, University of Cambridge), neuroscience (National Institutes of Health), and drug discovery (Helmholtz Institute). As a former researcher and technologist at heart, Shelby loves getting deep into the tech with founders and has >20 active bio and health theses. They’re dedicated to being a super high context and helpful thought partner for companies building in bio and health.